
Mitochondrial Delivery of Doxorubicin Using MITO-Porter Kills Drug-Resistant Renal Cancer Cells via Mitochondrial Toxicity
Keywords: cancer; liposomes; drug delivery systems; nanoparticles; nanotechnology; ATP; adenosine triphosphate; Ch; channel; Chol; cholesterol; CLSM; confocal laser scanning microscopy; DOPE; 1,2-dioleoyl-sn-glycero-3-phosphatidylethanolamine; DOX; doxorubicin; DSP